(Washington) — The Food and Drug Administration issued an administrative stay Tuesday on the order it issued last month for vaping company Juul to pull its electronic cigarettes from the market.
Twitter statement by the agency: “The stay temporarily suspends marketing denial orders while the agency conducts additional review. It does not repeal it.”
The FDA had issued the first order prohibiting Juul sales in June 23. One day later, the ban was temporarily blocked by an appeals court.
Following years of delays and regulatory failures, FDA initiated the initial FDA action.
Companies must prove that e-cigarettes are good for public health in order to remain on the market. It means that adult smokers using e-cigarettes are more likely to stop smoking or to reduce their use, and teens will not become addicted.
Continue reading: It’s Too Simple to Call the Juul Ban a Public Health Triumph
The FDA originally said Juul’s application left regulators with significant questions and didn’t include enough information to evaluate any potential health risks. Juul claimed it had provided enough data and information to resolve all the issues.
A three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit granted Juul’s request for a hold while the court reviews the case.
On Tuesday, the FDA said it has determined “there are scientific issues unique to the Juul application that warrant additional review.”
Still, it said, the stay and the review do not “constitute authorization to market, sell or ship Juul products.”
Read More From Time
